TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25457687

Group type: EXPERIMENTAL
Intervention: Yoga intervention
Number of subjects: 0
Study: 23221655

Group type: EXPERIMENTAL
Intervention: Active Parenting Today (APT) program with telephone counseling (2 hours/session/week for 8 weeks)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (no intervention details provided)
Number of subjects: 39
Study: 20685536

Group type: EXPERIMENTAL
Intervention: Delaire facemask (DFM)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Grummons facemask (GFM)
Number of subjects: 34
Study: 17919608

Group type: EXPERIMENTAL
Intervention: Oral or vaginal estroprogestative contraception
Number of subjects: 24

Group type: COMPARATOR
Intervention: No contraception (control group)
Number of subjects: 24
Study: 15910446

Group type: EXPERIMENTAL
Intervention: Foremilk
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Hindmilk
Number of subjects: 62

Group type: COMPARATOR
Intervention: Sterile water
Number of subjects: 62
Study: 12544289

Group type: EXPERIMENTAL
Intervention: High calcium diet
Number of subjects: 21
Study: 10394483

Group type: EXPERIMENTAL
Intervention: Low frequency transcranial magnetic stimulation (1 Hz) of left temporoparietal cortex
Number of subjects: 3

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 3
Study: 8855809

Group type: EXPERIMENTAL
Intervention: LPS (2 ng/kg) + hydrocortisone (3 micrograms/kg.min) for 6 h before LPS injection
Number of subjects: 23

Group type: COMPARATOR
Intervention: LPS (2 ng/kg) alone
Number of subjects: 23
Study: 1825469

Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Endocrine therapy
Number of subjects: 60
Study: 6841130

Group type: EXPERIMENTAL
Intervention: Special dietary counseling and supplements of Sustagen or Isocal
Number of subjects: 97

Group type: COMPARATOR
Intervention: No special advice or supplements (Control)
Number of subjects: 97
Study: 31281046

Group type: COMPARATOR
Intervention: Clinician reporting of angina freedom at baseline
Number of subjects: 912

Group type: EXPERIMENTAL
Intervention: Patient reporting of angina freedom at baseline
Number of subjects: 912

Group type: COMPARATOR
Intervention: Clinician reporting of angina freedom at 12 months
Number of subjects: 912

Group type: EXPERIMENTAL
Intervention: Patient reporting of angina freedom at 12 months
Number of subjects: 912

Group type: EXPERIMENTAL
Intervention: Overall agreement in CCS grade reporting
Number of subjects: 912

Group type: EXPERIMENTAL
Intervention: Discordant reporting of angina
Number of subjects: 912
Study: 28338459

Group type: EXPERIMENTAL
Intervention: Extended iliac port site incision
Number of subjects: 41

Group type: COMPARATOR
Intervention: Pfannenstiel incision
Number of subjects: 41
Study: 26744198

Group type: EXPERIMENTAL
Intervention: Chlorhexidine (0.2%) mouthwash
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Sodium fluoride (0.05%) mouthwash
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (no mouthwash)
Number of subjects: 75
Study: 23916631

Group type: EXPERIMENTAL
Intervention: Pleasant Events Program (PEP) intervention
Number of subjects: 100

Group type: COMPARATOR
Intervention: Information-Support (IS) control condition
Number of subjects: 100
Study: 21593370

Group type: EXPERIMENTAL
Intervention: Percutaneous compression plate
Number of subjects: 66

Group type: COMPARATOR
Intervention: Sliding hip screw
Number of subjects: 66
Study: 19620700

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 105
Study: 16837885

Group type: EXPERIMENTAL
Intervention: Ground flaxseed muffins (25 g, 50 mg lignans)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Soy flour muffins (25 g, 42 mg isoflavones)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Wheat flour muffins (control)
Number of subjects: 99
Study: 15326881

Group type: EXPERIMENTAL
Intervention: Polygraph Aware
Number of subjects: 50

Group type: COMPARATOR
Intervention: Polygraph Unaware
Number of subjects: 50
Study: 10933649

Group type: EXPERIMENTAL
Intervention: Dirithromycin (500 mg daily for 5 days)
Number of subjects: 439

Group type: COMPARATOR
Intervention: Erythromycin (250 mg every 6 h for 7 days)
Number of subjects: 439
Study: 9068309

Group type: EXPERIMENTAL
Intervention: Nebulised budesonide
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study: 8360133

Group type: EXPERIMENTAL
Intervention: Clarithromycin 250 mg bd
Number of subjects: 408

Group type: COMPARATOR
Intervention: Cefaclor 500 mg tds
Number of subjects: 408
Study: 3530781

Group type: EXPERIMENTAL
Intervention: Bucindolol 50 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Bucindolol 100 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Bucindolol 200 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 30837554

Group type: EXPERIMENTAL
Intervention: Combined oral contraceptive pill (COCP) exposure
Number of subjects: 95

Group type: COMPARATOR
Intervention: Current non-hormonal contraceptive practices (control)
Number of subjects: 95
Study: 28209155

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 24249840

Group type: EXPERIMENTAL
Intervention: Physical activity telemonitoring program (n=40), wore a motion sensor continuously for 18 weeks, received weekly step count goals.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard CR (n=40), wore an unreadable motion sensor for measurement purposes only.
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Physical activity telemonitoring program (n=40).
Number of subjects: 80
Study: 23598060

Group type: EXPERIMENTAL
Intervention: COMT rs4680 mutation group
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: COMT rs737865 mutation group
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: COMT rs165599 mutation group
Number of subjects: 140

Group type: COMPARATOR
Intervention: CHRNA7 SNPs
Number of subjects: 140
Study: 21365047

Group type: EXPERIMENTAL
Intervention: Allograft cellular bone matrix (ACBM)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Conventional allograft (CA)
Number of subjects: 21
Study: 18637070

Group type: EXPERIMENTAL
Intervention: pegylated interferon (pegIFN) plus ribavirin (RBV)
Number of subjects: 75
Study: 17129376

Group type: EXPERIMENTAL
Intervention: Diabetes Manual self-management educational intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomised trial
Number of subjects: 0
Study: 12751984

Group type: EXPERIMENTAL
Intervention: Contingency Management (CM)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Non-Contingency Management (non-CM)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Desipramine (DMI)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 12040471

Group type: EXPERIMENTAL
Intervention: G-CSF starting on day +1
Number of subjects: 87

Group type: COMPARATOR
Intervention: G-CSF starting on day +5
Number of subjects: 87
Study: 9687125

Group type: EXPERIMENTAL
Intervention: Therapeutic Touch (TT)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Sham Therapeutic Touch (sham TT)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 99
Study: 8077802

Group type: EXPERIMENTAL
Intervention: rHuEPO (recombinant human erythropoietin)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Verapamil
Number of subjects: 40

Group type: COMPARATOR
Intervention: Gallopamil
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ketanserine
Number of subjects: 40
Study: 2521696

Group type: EXPERIMENTAL
Intervention: ANF infusion
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 6
Study: 4615786

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide plus nandrolone phenylpropionate
Number of subjects: 2

Group type: COMPARATOR
Intervention: Cyclophosphamide alone
Number of subjects: 2
Study: 31856691

Group type: EXPERIMENTAL
Intervention: Cilostazol
Number of subjects: 1534

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 1534
Study: 30994720

Group type: EXPERIMENTAL
Intervention: Left Ventricular (LV) Pacing
Number of subjects: 91

Group type: COMPARATOR
Intervention: Right Ventricular (RV) Pacing
Number of subjects: 91
Study: 27908615

Group type: EXPERIMENTAL
Intervention: PLIF using double expandable PEEK cages without instrumentation (Group 2)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Simple discectomy (Group 1)
Number of subjects: 60
Study: 25682401

Group type: EXPERIMENTAL
Intervention: Joshi's external stabilization system (JESS fixator)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Complete subtalar release (Simons technique)
Number of subjects: 50
Study: 23508277

Group type: EXPERIMENTAL
Intervention: 0.6 g iodine/kg of TBW (n=33)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: 0.75 g iodine/kg of LBW (n=35)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: 22 g iodine/m(2) BSA (n=35)
Number of subjects: 103
Study: 21414998

Group type: EXPERIMENTAL
Intervention: Computer-tailoring print-based intervention
Number of subjects: 325

Group type: COMPARATOR
Intervention: Generic intervention
Number of subjects: 325
Study: 19324419

Group type: EXPERIMENTAL
Intervention: Olanzapine (5-20 mg/day)
Number of subjects: 788

Group type: EXPERIMENTAL
Intervention: Olanzapine/Fluoxetine Combination (OFC; 6/25, 6/50, or 12/50 mg/day)
Number of subjects: 788

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 788
Study: 17024635

Group type: EXPERIMENTAL
Intervention: Progressive endurance training (3 to 6 x 90 minute sessions per week at 70% V.O2max)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Progressive endurance training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Non-exercising control group
Number of subjects: 20
Study: 14967363

Group type: EXPERIMENTAL
Intervention: 3-month triptorelin SR
Number of subjects: 72

Group type: COMPARATOR
Intervention: 28-day triptorelin SR
Number of subjects: 72
Study: 11915622

Group type: EXPERIMENTAL
Intervention: Experimental fluoride-releasing tooth separator (polyurethane elastomer with tin fluoride)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 9564446

Group type: EXPERIMENTAL
Intervention: Moderately suprathreshold dose
Number of subjects: 11

Group type: COMPARATOR
Intervention: High dose
Number of subjects: 11
Study: 7769501

Group type: EXPERIMENTAL
Intervention: 6 g purified fish oil once a day for 6 months
Number of subjects: 350

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 350
Study: 30078106

Group type: EXPERIMENTAL
Intervention: High-intensity training (1-min sprints with 2 min active recovery, 3 days/week for 6 weeks)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High-intensity training
Number of subjects: 12

Group type: COMPARATOR
Intervention: High-intensity training and Control
Number of subjects: 12
Study: 27652697

Group type: EXPERIMENTAL
Intervention: 4% articaine with 1:100,000 epinephrine
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 2% lidocaine with 1:100,000 epinephrine
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 2% mepivacaine with 1:100,000 epinephrine
Number of subjects: 66
Study: 24345834

Group type: EXPERIMENTAL
Intervention: DHA supplementation (200 mg/day)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 22310398

Group type: EXPERIMENTAL
Intervention: Peripheral compartment starting point
Number of subjects: 60

Group type: COMPARATOR
Intervention: Central compartment starting point
Number of subjects: 60
Study: 19486477

Group type: EXPERIMENTAL
Intervention: Plyometric training (8 weeks)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 21
Study: 18679788

Group type: EXPERIMENTAL
Intervention: Open-class words
Number of subjects: 12

Group type: COMPARATOR
Intervention: Closed-class words
Number of subjects: 12
Study: 15723745

Group type: EXPERIMENTAL
Intervention: Fish Oil (FO) - 30 mL/d providing 4.9 g of eicosapentaenoic acid and 3.2 g of docosahexanoic acid for 4 weeks
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Melatonin (MLT) - 18 mg/d for 4 weeks
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Combination of Fish Oil and Melatonin for the next 4 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 24
Study: 12818444

Group type: EXPERIMENTAL
Intervention: FSH-HP and hMG (Group A)
Number of subjects: 45

Group type: COMPARATOR
Intervention: FSH-HP only (Group B)
Number of subjects: 45
Study: 10397212

Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine (NAC) treatment (150 mg/kg bolus followed by continuous infusion of 12 mg/kg/hr)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo (5% dextrose)
Number of subjects: 86
Study: 8873520

Group type: EXPERIMENTAL
Intervention: Tension-free hernioplasty with prolene mesh
Number of subjects: 208

Group type: COMPARATOR
Intervention: Cooper ligament repair
Number of subjects: 208

Group type: COMPARATOR
Intervention: Abdominal ring repair
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Tension-free hernioplasty for primary direct inguinal hernias
Number of subjects: 208

Group type: COMPARATOR
Intervention: Tension-free hernioplasty vs conventional herniotomies
Number of subjects: 208
Study: 1984216

Group type: EXPERIMENTAL
Intervention: TM‐2420 ambulatory blood pressure monitor
Number of subjects: 30
Study: 6336898

Group type: EXPERIMENTAL
Intervention: Cefoxitin
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Cefazolin
Number of subjects: 354

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 354
Study: 29614706

Group type: EXPERIMENTAL
Intervention: Yoga- and meditation-based lifestyle intervention (YMLI)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 58
Study: 27515720

Group type: EXPERIMENTAL
Intervention: Practice guideline for optimal symptom relief (intervention group)
Number of subjects: 367

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 367
Study: 24658476

Group type: EXPERIMENTAL
Intervention: Paramedian approach
Number of subjects: 74

Group type: COMPARATOR
Intervention: Midline approach
Number of subjects: 74
Study: 22414611

Group type: EXPERIMENTAL
Intervention: Acoustic coordinated reset (CR) neuromodulation
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 63
Study: 20460477

Group type: EXPERIMENTAL
Intervention: docetaxel plus ASA404 1,200 mg/m2 (A-D)
Number of subjects: 74

Group type: COMPARATOR
Intervention: docetaxel 75 mg/m2 alone (D)
Number of subjects: 74
Study: 19013751

Group type: EXPERIMENTAL
Intervention: Ropivacaine infiltration (40 ml of ropivacaine 4.75 mg/ml)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 15823991

Group type: EXPERIMENTAL
Intervention: Surface electrical stimulation (ES) for 20 min once daily, 6 days per week for 1 month
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (ES with stimulation intensity kept at zero)
Number of subjects: 24
Study: 12779107

Group type: EXPERIMENTAL
Intervention: DentiPatch (20% lidocaine)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Topical anesthetic (Hurricaine Dry Handle Swab, 20% benzocaine)
Number of subjects: 28
Study: 10348415

Group type: EXPERIMENTAL
Intervention: New therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 7791286

Group type: EXPERIMENTAL
Intervention: ProTon (PT)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Goldmann applanation tonometer (GAT)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Comparison of PT and GAT
Number of subjects: 85

Group type: COMPARATOR
Intervention: Comparison of central and peripheral IOP
Number of subjects: 85
Study: 1782305

Group type: EXPERIMENTAL
Intervention: 150 mg ranitidine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 300 mg ranitidine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 6801096

Group type: EXPERIMENTAL
Intervention: Lithium carbonate
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 30829753

Group type: EXPERIMENTAL
Intervention: Combined CO2 laser followed by topical 5‐fluorouracil (5‐FU) application
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combined CO2 laser followed by topical verapamil hydrochloride application
Number of subjects: 30

Group type: COMPARATOR
Intervention: CO2 laser monotherapy
Number of subjects: 30
Study: 29059409

Group type: EXPERIMENTAL
Intervention: Extended (4-week run-in)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Extended + FE
Number of subjects: 58

Group type: COMPARATOR
Intervention: Standard (1-week run-in)
Number of subjects: 58
Study: 27255954

Group type: EXPERIMENTAL
Intervention: No Endotracheal suction group ('No ET' Group)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Endotracheal suction group ('ET' Group)
Number of subjects: 175
Study: 24596911

Group type: EXPERIMENTAL
Intervention: Denture adhesive cream
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Denture adhesive strips
Number of subjects: 30

Group type: COMPARATOR
Intervention: Nonadhesive trial
Number of subjects: 30
Study: 23152962

Group type: EXPERIMENTAL
Intervention: PEG-only 0.7 g/kg/day in 2 divided doses
Number of subjects: 96

Group type: COMPARATOR
Intervention: PEG-EL 6.9 g in 1-4 sachets according to age for 4 weeks
Number of subjects: 96
Study: 20364686

Group type: EXPERIMENTAL
Intervention: Combination of clinical homeopathy and dynamic electrical neurostimulation (DENS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18681276

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (5-FU) at a concentration of 25 mg/mL applied topically for 1 minute, 4 times after tendon repair
Number of subjects: 48

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 48
Study: 15572656

Group type: EXPERIMENTAL
Intervention: Lengthening contractions (LC); average peak torque = 299 ± 18 N.m
Number of subjects: 8

Group type: COMPARATOR
Intervention: Shortening contractions (SC); average peak torque = 225 ± 7 N.m
Number of subjects: 8
Study: 12934466

Group type: EXPERIMENTAL
Intervention: Anti-cytokine therapy targeting TNF-alpha, IL-1, and IF-gamma
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New low-molecular inhibitors of cytokines
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of anti-cytokines with other antirheumatic drugs
Number of subjects: 0
Study: 11096191

Group type: EXPERIMENTAL
Intervention: Tuberculin (PPD) test (0.1 ml of PPD, 2 TU)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sodium lauryl sulphate
Number of subjects: 20
Study: 9072780

Group type: EXPERIMENTAL
Intervention: 30 mg lansoprazole
Number of subjects: 20

Group type: COMPARATOR
Intervention: 20 mg omeprazole
Number of subjects: 20
Study: 1443741

Group type: EXPERIMENTAL
Intervention: Intrathecal sufentanil 10 micrograms
Number of subjects: 24

Group type: COMPARATOR
Intervention: Epidural sufentanil 10 micrograms
Number of subjects: 24

Group type: COMPARATOR
Intervention: Intravenous sufentanil 10 micrograms
Number of subjects: 24
Study: 3510278

Group type: EXPERIMENTAL
Intervention: CAMP (cyclophosphamide, doxorubicin, methotrexate, and procarbazine)
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: MVP (mitomycin, vinblastine, and cisplatin)
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: VP-P (etoposide and cisplatin)
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: VDA-P (vindesine and cisplatin)
Number of subjects: 486

Group type: COMPARATOR
Intervention: Overall
Number of subjects: 486
Study: 30902023

Group type: EXPERIMENTAL
Intervention: Tailored advice based on mental health status
Number of subjects: 6323

Group type: COMPARATOR
Intervention: General advice following assessment of mental health status
Number of subjects: 6323

Group type: EXPERIMENTAL
Intervention: Both groups (screening and control)
Number of subjects: 6323
Study: 31913911

Group type: EXPERIMENTAL
Intervention: Amisulpride 10 mg (given twice, 2 hours apart)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Amisulpride 10 mg and Ondansetron 4 mg (given simultaneously)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 31725826

Group type: EXPERIMENTAL
Intervention: 3 months of oxaliplatin-based adjuvant chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 6 months of oxaliplatin-based adjuvant chemotherapy
Number of subjects: 0
Study: 30332403

Group type: EXPERIMENTAL
Intervention: Praziquantel (PZQ) at a single dose of 40 mg/kg
Number of subjects: 400
Study: 26179124

Group type: EXPERIMENTAL
Intervention: Prednisone (initiated at 10 mg every other day, titrated to a maximum of 40 mg/day over 16 weeks)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 11
Study: 22407196

Group type: COMPARATOR
Intervention: Ipratropium bromide (IB); nebulized, administered at 30-minute intervals for 2 hours
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (MgSO4); combined nebulized and intravenous bolus, administered at 30-minute intervals for 2 hours
Number of subjects: 124
Study: 22950884

Group type: EXPERIMENTAL
Intervention: Transparent decision model for rating drug-drug interactions
Number of subjects: 200
Study: 19803687

Group type: COMPARATOR
Intervention: THC 0.0 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: THC 29.3 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: THC 49.1 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: THC 69.4 mg
Number of subjects: 16
Study: 17653309

Group type: EXPERIMENTAL
Intervention: Pegasys, 180 ug injected subcutaneously once a week for 24 weeks
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Roferon-A 3 MU three times a week for 24 weeks
Number of subjects: 98
Study: 16116879

Group type: EXPERIMENTAL
Intervention: CarboMedics Reduced (CM‐R) valve
Number of subjects: 20

Group type: COMPARATOR
Intervention: Medtronic Hall (MH) valve
Number of subjects: 20
Study: 12394655

Group type: EXPERIMENTAL
Intervention: Mediterranean diet + statin treatment
Number of subjects: 1926
Study: 10853568

Group type: EXPERIMENTAL
Intervention: Lidocaine 2%
Number of subjects: 50

Group type: COMPARATOR
Intervention: Lidocaine 2% with epinephrine 1:80,000
Number of subjects: 50
Study: 7848072

Group type: EXPERIMENTAL
Intervention: Supine training position (SUP, n = 7)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sitting training position (SIT, n = 7)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Both SUP and SIT groups
Number of subjects: 14